AI assistant
Sending…
Actinium Pharmaceuticals, Inc. — Director's Dealing 2016
Jun 1, 2016
34570_dirs_2016-05-31_064d5c48-9e55-4e7c-80e9-f64383463e81.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Actinium Pharmaceuticals, Inc. (ATNM)
CIK: 0001388320
Period of Report: 2016-05-26
Reporting Person: Memorial Sloan-Kettering Cancer Center (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-05-26 | Common Stock | S | 27168 | $1.92 | Disposed | 5389745 | Direct |
| 2016-05-26 | Common Stock | S | 12700 | $1.93 | Disposed | 5377045 | Direct |
| 2016-05-26 | Common Stock | S | 200 | $1.935 | Disposed | 5376845 | Direct |
More from Actinium Pharmaceuticals, Inc.
Delisting Announcement
2026
May 29
Annual Report
2026
Mar 30
Declaration of Voting Results & Voting Rights Announcements
2026
Mar 26
Board/Management Information
2026
Feb 13
Declaration of Voting Results & Voting Rights Announcements
2025
Nov 26
Interim / Quarterly Report
2025
Nov 14
Annual Report
2025
Nov 5
Proxy Solicitation & Information Statement
2025
Nov 5
Director's Dealing
2025
Aug 20
Interim / Quarterly Report
2025
Aug 8